Intensive antithrombotic therapies reduce ischaemic complications of percutaneous coronary intervention for ST-segment elevation myocardial infarction, but at a cost of increased bleeding. Bivalirudin ...
Please provide your email address to receive an email when new articles are posted on . Abridged dual therapy followed by direct oral anticoagulant monotherapy after PCI may be safe vs. 1 year of dual ...
Adding either argatroban or eptifibatide to thrombolytic therapy doesn't improve function following an ischemic stroke, results of new research show. "Ultimately, we found no benefit for either ...
The final report from the HORIZONS-AMI trial in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction shows that the early benefits of ...
Physicians should aim to use the least amount of antithrombotic therapy as possible in their patients undergoing TAVI, according to a new European consensus statement. In general, over the long term, ...
A phase II trial of a novel, lesion-directed antithrombotic agent shows no effect on preventing myocardial injury in low-risk patients undergoing PCI, but the safety profile was good with few bleeding ...
Antithrombotic therapy in clinically stable, nonhospitalized COVID-19 patients does not offer protection against adverse cardiovascular or pulmonary events, new randomized clinical trial results ...
Please provide your email address to receive an email when new articles are posted on . Transcatheter aortic valve replacement has revolutionized the management of aortic stenosis in recent years.
Each year, there are approximately 10 million cases of venous thromboembolism (VTE) worldwide. VTE, the formation of blood clots in the vein, is a dangerous and potentially deadly medical condition ...
There is increasing interest in the potential role of antithrombotic agents in the management of cancer patients. Low molecular weight heparins (LMWHs) have generated particular excitement because ...
The American Society for Gastrointestinal Endoscopy has released new guidelines regarding the management of antithrombotic agents for endoscopy, aspirin and/or NSAIDs that say the agents may be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results